The FDA's New Psychedelic Rules Are Groovy, but the Agency Is Still a Bad Trip
The new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Full article not available — click below to read at the source.
The new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Full article not available — click below to read at the source.
Comments
No comments yet. Be the first.
Sign in to leave a comment.